A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumours (KEYNOTE 158)
In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumours that have progressed on standard of care therapy will be treated with pembrolizumab.
Primary Outcome:
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the Canadian Cancer Society
